Biological Containment Isolation System (BCIS)

STATEMENT OF OBJECTIVE (SOO) DISTRIBUTION A. Authorized for public release, distribution unlimited. PROJECT TITLE: Biological Containment Isolation System (BCIS) BACKGROUND The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) and Joint Project Manager for CBRN Protection are seeking innovative biological containment, isolation, and quarantine (BIQ) capabilities for managing High-Consequence Infectious Disease (HCID) infected patients during contingency operations, in locations both in the Continental United States (CONUS) and Outside CONUS (OCONUS). The desire is for a modular, field-installable kit that will allow the conversion of the United States Air Force UTS Systems - Tactical Military Tall 60 (TMT60) positive pressure tent shelter to a negative pressure Multi-Patient BCIS tent / shelter. The BCIS will allow medical staff to monitor and/or treat patients while decreasing the risk of infecting other patients and staff. ACQUISITION STRATEGY & OBJECTIVES This Statement of Objectives (SOO) defines the goals for a multi-phased prototype project. 3.1 Acquisition Approach Subject to the availability of funds, the Government intends to make multiple awards for prototype solutions. Up to three (3) contractors will be selected for Phase I. Following Phase I, the Government will conduct a down-selection to determine which contractors (up to two) will proceed to Phase II. An award to participate in Phase I is a prerequisite for consideration for Phase II. To be considered successful and eligible for a non-competitive follow-on production award after Phase II, a prototype must meet the following criteria. The Government reserves the right to update or refine evaluation criteria prior to Phase II award to ensure alignment with program objectives and operational needs, provided such updates do not alter the requirements specified in Attachment 1. Table 1: Successful prototype criteria. Requirement Threshold Force Protection Negative pressure differential of 0.01 In.w.g ≥12 Air Changes per Hour (ACH) 99.97% at 0.3-micron particle diameter System Interruption Visual alarm when pressure is outside the required negative pressure range Patient Access Anteroom allows personnel and a litter-bound patient ingress/egress while maintaining negative pressure Modularity & Reversibility The TMT60 tent must be fully returnable to its original configuration. Modifications must either be fully removable without damage or, if left in place, must not interfere with the tent's original form, fit, or function. Directional Airflow Clean air inlet and filtered air exhaust should be positioned to maximize airflow, optimally at diagonally opposite corners in rectangular tents. Floor The kit must secure the floor against the ground to prevent "mushrooming" and maintain tautness and trip-free conditions under negative pressure. Walls Supplementary structural components must be included to prevent inward collapse and minimize deflection of tent walls, integrating with the existing frame. Doors Entry/exit doors must be modified or replaced to be outward-swinging, form a tight seal, resist deformation from negative pressure, and have a robust latch operable by a single person wearing medical PPE from both sides. Patient Movement System accommodates movement of patients on standard litters (94” x 31”) while maintaining negative pressure Power Connects to and operates on power from existing TMT60 tent The solution must operate at normal temperature IAW MIL-STD 810H and pressure (between 0.69 atm - 1 atm) Reusability System can be safely decontaminated and reused Noise Level The noise generated by the solution shall not exceed the levels of the equipment (e.g, generator, air filtration system, environmental control solution) used with the TMT60 shelter Shelf Life 5 years (filters) / 10 years (non-filters) Environmental No operational degradation from wind, rain, sand, or dust EMI Meets applicable MIL-STD-461 and MIL-STD-464 Transportation Must demonstrate ability to be transported in stored configuration Occupancy Isolation room to accommodate two single-patient HCID units (118 in L X 54 in W X 76 in H) and four litters (94 in L X 31 in W). Regulatory Compliance System must meet all regulatory compliance requirements (e.g. CDC, FDA, OSHA, NIOSH, DOT) for safe operation and to minimize risk of exposure to other personnel, as required. 3.2 Follow-on Production Authority Upon successful completion of a prototype Other Transaction Authority (OTA) competitively awarded from this SOO, the Government may issue a follow-on production contract for up to 15 units without further competition, in accordance with 10 U.S.C. § 4022. 3.3 Proposal Requirements Offerors shall use this SOO as the basis for preparing a draft Statement of Work (SOW), which will be included as an integral part of the proposal. The proposal shall address the objectives of each phase for a multi-patient solution and include a draft Statement of Work (SOW) for the Government's consideration. Multiple SOW submissions per Offeror are acceptable. This project is unclassified. The proposal must contain the following distinct elements: A detailed master delivery schedule for all prototypes and data deliverables. The total firm-fixed-price for all prototypes and associated deliverables in each Phase. The Offeror's projected unit cost for a potential Full Rate Production (FRP) quantity. The Offeror's demonstrated or projected maximum monthly production rate. Supporting documentation to substantiate performance claims, including but not limited to: Technology Readiness Level (TRL) data, production lead times, test plans and reports, High Consequence Infectious Disease (HCID) containment data, analysis of interoperability with existing military field hospitals, power requirements, and durability data. 3.4 Phased Objectives The following objectives apply to…